Most studies evaluating epidemiologic relationships between helminths and HIV have been conducted in the pre-ART era, and evidence of the impact of helminth infections on HIV disease progression remains conflicting. Less is known about helminth infection and clinical outcomes in HIV-infected adults receiving antiretroviral therapy (ART). We sampled HIV-infected adults for eight gastrointestinal parasites and correlated parasitic infection with demographic predictors, and clinical and immunologic outcomes. Contrasting with previous studies, we measured parasitic infection with a quantitative, highly sensitive and specific polymerase chain reaction (PCR) method. This cohort study enrolled HIV-infected Ugandans from August-September 2013 in Mbale, Uganda and collected stool and blood samples at enrollment. 
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Introduction
Five soil transmitted helminth species Ascaris lumbricoides, Trichuris trichiura, hookworm species Necator americanus and Ancylostoma duodenale, and Strongyloides stercoralis infect over a billion people worldwide. [1, 2] The burden of parasitic infection is greatest in low-income areas, particularly in certain areas of sub-Saharan Africa, where human immunodeficiency virus (HIV) is also highly prevalent. Studies of African adults living with HIV have shown helminth co-infection rates that range from 10% to upwards of 45%. [3] [4] [5] [6] [7] [8] [9] To date, the majority of research investigating the impact of intestinal helminth infection on HIV disease progression has occurred prior to widely available antiretroviral therapy (ART). [3, 4, [9] [10] [11] [12] [13] The effect of helminth and HIV co-infection in the presence of ART is less well characterized. Indeed, to our knowledge, only two studies to date have examined the impact of deworming on CD4
+ recovery in persons receiving ART. [14, 15] The current literature examining the relationship between soil transmitted helminth infections and HIV in the pre-ART era presents an inconclusive picture. The large body of observational data is mixed. Two observational cohort studies found no beneficial effect of deworming on HIV viral loads and CD4 + T-cell concentrations, [4, 5] while another suggested the possibility of a protective effect of helminths on decreasing HIV viral replication. [3] Of the three randomized experiments evaluating the impact of deworming on markers of HIV disease progression without ART, two found an improvement in either CD4 + T-cell concentrations or HIV viral load after anthelmintic therapy. [9, 13] Another larger, reflexive randomized deworming trial failed to show a statistically significant benefit of empiric deworming treatment versus standard of care in preventing HIV progression to either a CD4 + count of <350 cells/mcL, first reported use of antiretroviral treatment, or death due to a non-traumatic cause (44.0 versus 49.8 events per 100 person-years; hazard ratio = 0.88, 95%CI 0.74 to 1.04, P = 0.10). [10] However, it is possible that there was a less extreme benefit to presumptive therapy, which they were underpowered to detect. Interactions between soil-transmitted helminths and their human hosts are complex, and helminth infection may influence a patient's relationship with other pathogens. A recent review discusses not only the links between selected parasites and HIV susceptibility and disease progression, but also the relationship between soil transmitted helminths and the potential for increased susceptibility to malaria and tuberculosis. [16] [17] [18] It is also important to recognize that soil transmitted helminths, through their potent and systemic T helper cell type 2 (Th2) cytokine and regulatory responses, [19] may induce Th2 protective effects that could benefit long-term HIV survivors, e.g. protection against conditions associated with chronic inflammation. [20] [21] [22] [23] However, this same Th2 immune response may mediate increased susceptibility for Th1-related infections. [24] At present, integrated presumptive anthelmintic therapy in the context of HIV care is neither recommended by Ugandan National Guidelines, [25] nor is it recommended by WHO. [26] While WHO does recommend periodic so called "preventive chemotherapy" for high risk groups, including women of child bearing age and adults with occupational exposures, [27] these guidelines have generally not been integrated into any type of standard care, nor has particular emphasis been given to HIV-infection. Given the frequency and consistency with which HIV-diagnosed persons interact with their care providers, the integration of adult deworming programs into HIV care may be a logical conclusion. [28] However, given the dearth of high quality and adequately powered species-specific studies, dramatic increases in ART availability, and incomplete understanding of biological mechanisms that are impacted by helminths during HIV infection implies that research questions focused on soil transmitted helminths and HIV have not been exhausted.
Our current study evaluated the prevalence and burden of the five most common soil-transmitted helminths and three protozoal species in adults living with HIV enrolled in outpatient HIV care in peri-urban Uganda. We also evaluated the relationship between helminth infection and clinical and immunologic outcomes, and examined risk factors for helminth infection in this population.
Methods

Ethics statement
Written informed consent was provided by all participants. The University of Minnesota, The AIDS Support Organisation (TASO), and the Uganda National Council of Science and Technology institutional review boards approved this protocol.
Participant recruitment and data collection
From August through September 2013, we screened HIV-infected adults engaged in outpatient care at the TASO HIV clinic in Mbale, Uganda, during their normal clinical visit for a onetime stool sample analysis, and longitudinal follow-up via chart review. This study was powered to estimate overall parasitic infection prevalence among patients with a recent CD4+ T cell count <500 cells/mcL, a population of approximately 600. We estimated a sample size of 210, based on a true population prevalence of 30%, an alpha level of 0.05, 5% precision estimate, and a finite population size of 600.
Inclusion 
Biological sample collection and analyses
We collected blood and stool from participants during their study visit, which was also a participant's normal clinic visit. We performed a single blood draw to evaluate CD4 + T cell count via the FACSCalibur flow cytometer (BD Biosciences, San Jose, CA) per routine TASO laboratory protocol. Parasitic infection status was only evaluated at one time-point: study enrollment. Participants provided a single stool sample, which we froze without fixatives on site at -20˚C within 1-2 hours of collection. Stool specimens were transported on a weekly basis to Kampala, Uganda for long-term -80˚C storage during enrollment. At the Translational Research Laboratory of the Infectious Diseases Institute in Kampala, Uganda, we used a modified version of a validated quantitative PCR described previously in Mejia et al. to assess participant stool for Ascaris lumbricoides, Ancylostoma duodenale, Necator americanus, Strongyloides stercoralis, Trichuris trichiura, Cryptosporidium spp., Entamoeba histolytica, and Giardia intestinalis infection. [29] This PCR assay was modified to increase the total volume of each reaction from 7μL to 10μL to accommodate the minimum settings on the Applied Biosystems 7900HT Fast Real-Time PCR System. Reagent concentrations of the 10μL reaction matched those of the 7μL reaction concentrations. [29] DNA was extracted from approximately 50mg of stool via the FastDNA SPIN Kit for Soil (MP Biomedicals, Santa Ana, CA) using a low reagent method developed by Mejia et al. for resource-limited contexts, which has been included as S1 DNA Extraction Protocol. An additional step was required to extract T. trichiura DNA, whereby the remaining insoluble pellet from one DNA extraction was re-suspended in 200μL DNA-free water, heated at 90˚C for 10 minutes, and centrifuged at 14,000g for 10 minutes. We then repeated the above-described DNA extraction method to process the resulting soluble portion of the sample.
Sequences for the species-specific primers and probes and methods for the qPCR analysis are found in Mejia et al. [29] All control standards were tested in triplicate, and all unknown samples were tested in duplicate. A PCR cycle threshold (C t ) value >38 was considered a negative result. To help ensure that false positives were not driving our results, we conducted a post hoc experiment to bind the N. americanus primers and probes to the pBR322 internal control plasmid.
[30] We did not observe any evidence of binding between the N. americanus primers or probes and the pBR322 control plasmid.
Parasite burden quantification was performed by interpolating against parasite specific sequences standards and reported as DNA fg/μl. [29, 31] Briefly, egg counts were estimated from McMaster microscopy techniques of subjects infected with N. americanus and/or A. duodenale and compared directly to qPCR results. Estimated egg counts from qPCR were calculated using Y ova/g feces = 0.03472 Ã X fg/μl per correlation studies.
[31] Similar calculations were used to estimate Trichuris trichiura egg counts: Y ova/g feces = (1.095 x 10 −5 ) Ã X fg/μl , which was derived by comparing qPCR to Kato-Katz results in infected individuals. [29] Statistical analyses Parasite infection prevalence was estimated overall, by species, and by species type (protozoa or nematoda). Infection intensity was summarized by species for helminth worms. [32, 33] Statistical analyses focused on hookworm infection a posteriori, due to its unique immunologic and clinical features, and overwhelming prevalence relative to other species of helminths. We used generalized linear models with a binomial distribution and log link, and a robust covariance estimator, to estimate associations between parasitic infection (overall helminth infection, hookworm infection only, and protozoa infection) and clinical and demographic characteristics, specifically occupation (farming as primary profession versus any other), sex, age (scaled to 5-year increments), weight (scaled to 5-kg increments), WHO Clinical Stage (3 or 4 versus 1 or 2), ART status (receiving or not receiving).
We also estimated the association between parasitic infection and CD4 + T cells/mcL at study enrollment, and the potential effect of parasitic infection on over CD4 + T cell concentrations over follow-up. Age-, and sex-adjusted linear regression models estimated the mean difference in CD4+ T cells/mcL at study enrollment by parasitic infection status (any protozoa, any helminth, hookworm only). Restricted maximum likelihood linear mixed models, which included participant-specific random intercepts, and an identity covariance matrix, evaluated change in CD4+ T cell concentrations over time across hookworm infection status among participants who were ART-initiated at baseline. These longitudinal models were adjusted for sex, age, time on ART, and weight at baseline. Additional exploratory sub-analyses of change in CD4+ T cell concentrations by hookworm infection status were performed among 1) participants who had initiated ART <1 year before enrollment, and 2) participants who had initiated ART for !1 year before enrollment. Time on ART, weight, sex, and age were a priori included as covariates given their relationship with either the outcome, or to control for potential confounding, e.g. age.
We attempted to evaluate the relationship between CD4 + T cell count and parasite burden (light, moderate, and heavy intensity infections per WHO classification). However, because all infections were classified as light intensity (<2,000 eggs/gram feces), we were unable to create any clinically meaningful exposures beyond presence or absence of hookworm infection. No imputation was performed for missing data, which occurred in <2% of participants. All analyses were performed in Stata/IC 13.1 (StataCorp, College Station, Texas) and results were evaluated against an alpha level of 0.05.
Results
We consented 216 HIV-infected adults during a routine clinic visit. Of these, 14 potential participants were unable to produce a stool sample on site, and were excluded from the study. Thus, 202 participants were enrolled ( 
Relationship between hookworm and immune status
We assessed the relationship between hookworm infection and CD4 + T helper cell concentrations at study enrollment. Participants with hookworm infection demonstrated consistently lower concentrations of CD4 + cells/mcL when compared to hookworm-uninfected peers (Table 4) (min = 1, max = 5) (Fig 1) . The mean number of measurements over time across hookworminfected versus uninfected participants was similar (2.2 and 2.4, respectively). At 12 months post-enrollment, predicted means from sex-, age-, time on ART-and baseline weight-adjusted linear mixed models estimated that participants with hookworm infection had an average of 361 CD4 While participants with hookworm infection still had lower CD4+ cell concentrations than their uninfected peers at 24 months of follow-up, the difference in average CD4+ cells/mcL between hookworm infected versus uninfected across groups was attenuated (-30 cells/mcL; 95%CI -114, 55) and not statistically significant. Furthermore, participants who had initiated ART !1 year prior to study enrollment (n = 108) demonstrated a similar relationship to our overall cohort; there was no difference in rate of CD4+ cell recovery during the study period, but those with hookworm were at an immunologic deficit relative to their uninfected peers (77 fewer CD4+ cells/mcL in those with hookworm versus those without; 95%CI -154, -1). Among persons who had initiated ART <1 year prior to study enrollment (n = 68), the effect was less pronounced, with only 26 (95%CI: -121, 70) fewer CD4 cells/mcL in those with hookworm versus those without, and no difference in change over time, like other analyses.
Discussion
We demonstrate that parasitic infection, particularly with N. americanus hookworm species, was common in this adult, HIV-infected population in Uganda. While these infections were generally light intensity infections, we report a clinically and statistically significant association between hookworm infection and decreased CD4 + T helper cells/mcL at study enrollment.
This relationship was maintained over study follow-up, where participants with hookworm infection had diminished CD4 + immune status over time, relative to their peers who were not infected with hookworm. There was no difference, however, in CD4 + cell recovery over 24 months among participants who were ART-initiated at baseline. To our knowledge, only two other studies to date have examined the health impacts of helminth infection in persons receiving ART, specifically the effects of deworming. [14, 15] In Uganda, Lankowski et al. did not find any significant beneficial effects of deworming in their overall study population. However, in a sub-group analysis of women only, they found that deworming with either albendazole or mebendazole 7 to 90 days prior to CD4 + T cell measurement, for unspecified parasitic infection increased CD4 + T helper cell concentrations by an average of 63 cells/mcL (95% CI: 6-120) in in the first year of ART initiation. This study was limited by the fact that a medical record of deworming was used as a proxy for helminth infection, and as such neither helminth infection prevalence nor deworming incidence were reliably captured. This may have attenuated their results towards a null finding in the overall cohort.
Ivan et al. found that deworming decreased HIV viral loads and increased CD4 + T cell concentrations over a 12-week period in a cohort of 980 HIV-infected, ART-initiated pregnant Rwandans. [15] While the results of this study demonstrate the value in revisiting the question of deworming in the presence of increasingly available ART, it is potentially limited by a treatment cross-over effect of deworming outside of the study setting. That said, any extra-study deworming in the control arm would likely attenuate the effects of their intervention; and one can extrapolate that the results in a completely controlled setting would have been more extreme. Additionally, this is a limited subset of the ART-receiving, HIV-infected population, and it would be important to duplicate these results in other populations of men and nonpregnant women.
Prevalence of parasitic infection
Our results are comparable with much of the available literature regarding parasite infection prevalence in adults. Other studies conducted in Uganda have found similar prevalences of hookworm infection (24 to 52%), [35] [36] [37] [38] [39] and Strongyloides (4 to 8%) [40] [41] [42] in adults with and without HIV. In persons with HIV in Nigeria, Senegal, and Ethiopia, Giardia prevalence has been observed at approximately 5%. [43] [44] [45] Partial immunity to most parasitic infections is acquired over the life course, leading to an increased rate of parasite destruction and worm expulsion with increasing age and re-infection. Hookworm species, however, do not induce the same adaptive immunity in humans as the other soil transmitted helminths, and consequently, may continue to infect adults with high frequency and intensity. [46] In the context of frequent and repeated infection, this lack of adaptive immunity may have important implications for host response to co-infections like HIV, and important Th1-moderated HIV co-morbidities, such as tuberculosis and cryptococcal meningitis.
Relationship between hookworm infection and CD4 + T cells/mcL
Our results found that participants who were infected with hookworm were at a significant CD4 + T-helper cells/mcL deficit, relative to participants who were not infected with hookworm. CD4 + T-helper cells are critical in mediation of the immune system's response to various pathogens, and commonly used to monitor HIV disease progression and response to ART. [47] The inverse relationship between hookworm infection and CD4 + T cell concentrations was qualitatively and statistically consistent across various analyses, from unadjusted to adjusted regression, analyses restricted to persons receiving ART, and over time. We did not observe a difference in CD4 + cells/mcL among persons who were ART-naïve; however, the small proportion of persons not receiving ART in this cohort (n = 19) renders these analyses relatively uninformative. Ample evidence demonstrates that soil-transmitted helminths are potent immunomodulators, and infection with soil-transmitted helminths involves many major body systems, from the gastrointestinal and circulatory systems, to soft tissues. [19] Multiple biologic mechanisms could be driving our observed relationship; and these results are likely multifactorial for any given participant. Hookworm infection in HIV-uninfected persons with celiac disease has been shown to decrease expression of interferon (IFN)-γ on intestinal T cells, and increase in CD4 + FoxP3 + regulatory T cells, which could contribute to decreased differentiation to CD4 + T helper cells. [48] Other research has demonstrated that hookworm antigens induce cytotoxic and pro-apoptotic activity in Jurkat T Cells, contributing to an increase in CD4 Other human studies have not found differences in CD4 + T cell concentrations between hookworm-infected and -uninfected groups of HIV-uninfected participants. In a quasi-experimental study by George et al., which measured the impact of deworming on microbial translocation (a contributor to chronic immune activation linked to decreased concentrations of CD4 + T helper cells), observed that hookworm was associated with elevated levels of proinflammatory markers, e.g. lipopolysaccharide, soluble CD14.
[52] They did not, however, observe differences in T cell subsets among naturally infected, HIV-uninfected participants at baseline. [52] The authors postulate that lack of difference in T cell subsets is mediated by a counterbalancing, anti-inflammatory effect of hookworm infection, e.g. elevated levels of IL-10, and decreased C-reactive protein, IL-17 and haptoglobin. [52] From the standpoint of clinical endpoints, results from clinical trials conducted in ARTnaïve persons remain mixed. Results from the HEAT trial, which evaluated the impact of reflexive and repeated deworming on a patient's risk for ART eligibility, i.e. a drop below 350 CD4 + cells/mcL, found no difference between the reflexive deworming group (400 mg albendazole every 3 months plus 25 mg/kg praziquantel annually) versus the standard of care group (no empiric deworming).
[10] The trial had 80% power to detect a hazard ratio of 0.775, which could be considered a large, albeit clinically important, difference in treatment groups. That said, actual CD4 + T cell concentrations at study completion were very similar across randomization groups, supporting the idea that deworming may not dampen CD4 + decline in the absence of ART. Other studies support this conclusion. [4, 5, 53] However, still other studies and meta-analyses demonstrated reductions in plasma viral loads and increases in CD4 + T
helper cells with deworming in persons living with HIV. [13, 54] The differences in these results may in part be explained by differences in methodology, and in particular the need to pool species due to limited species-specific sample sizes. Repeated and long-term exposure to hookworm and other helminth species may cause fibrosis of the gut associated lymphatic tissues (GALT). IL-13, in particular, is increased in the presence of hookworm infection [46] and a dominant mediator of fibrotic tissue, which induces fibrosis independently and via simulation and activation of transforming growth factor (TGF)-β. In the case of chronic and repeated helminth infections, and corresponding Th2 type immune responses, IL-13 production can become pathological. Fibrosis of the GALT has been linked to the dysregulation of immune cells, including CD4 + T cells, and impaired CD4 + recovery. [55, 56] Chronic and repeated exposure to helminths and subsequent GALT fibrosis may have impacted the results of this and other studies. Indeed, the longitudinal analyses in this study demonstrate that hookworm-infected versus uninfected participants have a similar rate of CD4 + recovery over the 24-month follow-up period, but that those infected with hookworm remained at a significant immunologic deficit relative to their uninfected peers over time.
Fibrosis is not reversible with deworming or other therapy. This bears mentioning because while hookworm and other helminths are still causally implicated in the decrease in CD4 + T cell concentrations, there are important implications for public health intervention design, e.g. increased deworming frequency targeting all stages of the human life course.
Limitations
It is possible that our results are spurious, either due to confounding, a misunderstanding of the directionality of the hookworm-CD4 + relationship, or a type I statistical error. Finally, our results may be confounded by data that would have been useful in these analyses but were not available. Hookworm, and other intestinal parasites, are considered diseases of poverty. The relationship between increased infection incidence among economically disadvantaged persons is well established. [38, [67] [68] [69] Additionally, being economically disadvantaged could have impacted health outcomes in this study, e.g. CD4
+ T helper cells concentrations, as it has in other research. [70] [71] [72] While we collected information on place of residence, this information could ultimately only be dichotomized into participants who lived in Mbale town, where the clinic is located, versus all others, which could represent varied levels of development and corresponding hookworm exposure. Also, ART adherence data were routinely collected and reflected uniformly high adherence levels. Past research on adherence at TASO ART clinics report similarly high levels of ART adherence, with~90% of patients reporting no missed pills in the past 30 days. [73] [74] [75] However, data from prior TASO adherence research-like adherence data for this study-are limited by the fact that they are self-reported, which consistently over-reports adherence relative to pill counts, pharmacy refill information, and/or drug concentrations in blood. [76, 77] 
Conclusions
Despite the limitations of this study, we feel that these results are generalizable to other adults receiving outpatient HIV therapy in low-income, peri-urban areas. The results presented herein point to a high prevalence of helminth infection in this vulnerable population, and that hookworm infection is associated with sub-optimal health outcomes, i.e. lower CD4. Therefore, further examination of these questions via a randomized trial is warranted, especially how systematic deworming may impact the immune status of this vulnerable population in the presence of ART. 
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